Dr. Jacob Teitelbaum, a specialist in chronic fatigue syndrome and fibromyalgia, uses a holistic approach to treating fibromyalgia called S.H.I.N.E.
Diagnosed in 2004 with fibromyalgia, Linda Thornrose is always in pain and deals with chronic insomnia. What she wishes most is that people would understand that this is a real disease and offer some kindness.
Dr. Marc Riedl has specialized in treating primary immune deficiency patients for more than 12 years.
Just as it was impossible for previous generations to predict today’s scientific and technological advances, we are similarly challenged when looking to the future. But the path to progress begins with innovation.
Symptoms of immune deficiency began when Dona Darr’s daughter, Emily, was just a toddler. What started as an ear infection turned into nearly a decade-long quest for an accurate diagnosis.
Dr. Dietrich Klinghardt, whose practice treats mostly late-stage Lyme patients after treatment has failed under the care of other healthcare practitioners, uses a systemic and local approach to treatment.
Regina Weichert suffered for years from the effects of Lyme disease but finally found a successful treatment from a doctor who utilized an out-of-the-box approach.
In the 21st century, it is anticipated that vaccines will play an equally significant role, addressing issues that include increased life expectancy, emerging infections and childhood mortality in developing countries.
Dr. Ronald Sokol’s life work revolves around the research and treatment of childhood liver diseases and other pediatric disorders.
This safety-themed edition of BioSupply Trends Quarterly addresses this patient safety and how it can be improved.
Major depressive disorder is a prevalent condition, but with swift and
appropriate treatment, the chance of recurrence can be minimized.
Mark Harris, PhD, is the founder and chief executive officer of NextGxDx, a healthcare information company that provides a web-based genetic diagnostics marketplace.